| Date | Title | Description | Source |
| 30.05.2023 | Positive results for Swiss biotechs’ clinical studies | | startuptic... |
| 16.01.2023 | Listed Swiss Biotechs at full throttle | | startuptic... |
| 14.01.2022 | Molecular Partners Reports Disclosure of Major Shareholder a... | ZURICH-SCHLIEREN, Switzerland & CONCORD, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Ad hoc announc... | marketscre... |
| 10.01.2022 | Novartis : COVID-19 news feed | Find the latest coronavirus (COVID-19) news from Novartis regarding clinical trials, collaborations,... | marketscre... |
| 10.01.2022 | Molecular Partners’ COVID-19 drug demonstrates efficacy | | startuptic... |
| 14.12.2021 | Molecular Partners : Announces Collaboration with Novartis t... | Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Th... | marketscre... |
| 14.12.2021 | Molecular Partners Announces Collaboration with Novartis to ... | Collaboration to leverage world class capabilities of Molecular Partners DARPin platform with Novart... | marketscre... |
| 03.12.2021 | Molecular Partners Announces Research Collaboration with Uni... | Research collaboration with leading acute myeloid leukemia (AML) experts,
Professor Ochsenbein and
P... | marketscre... |
| 16.11.2021 | Molecular Partners' Covid 19 drug falters in Phase 3 trials | | startuptic... |
| 04.11.2021 | Molecular Partners Announces First Patient Dosed with CD40 T... | Second immuno-oncology DARPin candidate to enter the clinic; combines immune stimulation with valida... | marketscre... |
| 28.10.2021 | Interim Management Statement Q3 2021 of Molecular Partners: ... | Interim Management Statement Q3 2021 of Molecular Partners: Advancement of COVID-19 Clinical Program... | marketscre... |
| 28.10.2021 | Interim Management Statement Q3 2021 of Molecular Partners: ... | ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Ad hoc announcem... | marketscre... |
| 21.10.2021 | Novartis : COVID-19 news feed | Find the latest coronavirus (COVID-19) news from Novartis regarding clinical trials, collaborations,... | marketscre... |
| 27.08.2021 | Molecular Partners : Reports Corporate Highlights and Key Fi... | Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
-- Significant progre... | marketscre... |
| 26.08.2021 | Molecular Partners : Reports Corporate Highlights and Key Fi... | -- Significant progress in COVID-19 trials, including positive results from healthy subjects and COV... | marketscre... |
| 21.06.2021 | Encouraging progress of COVID-19 solutions from Switzerland | CHF 1 million for a next-generation vaccine
The University Hospital Basel (USB), the University of B... | startuptic... |
| 21.06.2021 | Encouraging progress of COVID-19 solutions from Switzerland | | startuptic... |
| 16.06.2021 | MOLECULAR PARTNERS AG
Molecular Partners : Announces Pricin... | Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the... | marketscre... |
| 13.06.2021 | MOLECULAR PARTNERS AG
Molecular Partners : Announces First ... | Molecular Partners Announces First Patient Dosed in COVID-19 NIH-Sponsored ACTIV-3 Trial Evaluating ... | marketscre... |
| 09.06.2021 | MOLECULAR PARTNERS AG
Molecular Partners : Announces Launch... | Molecular Partners Announces Launch of American Depositary Shares (ADS) Offering in the United State... | marketscre... |
| 06.04.2021 | MOLECULAR PARTNERS AG
Molecular Partners : Announces First ... | Molecular Partners Announces First Patient Dosed in a Phase 2 Clinical Trial of Ensovibep in COVID-1... | marketscre... |
| 15.03.2021 | With hopes for antibodies waning, the NIH will test Nov... | After a slew of failures, the NIH’s ACTIV-3 trial for hospitalized Covid-19 patients has ear... | endpts.com... |
| 25.11.2020 | Development milestones for startups with Corona solutions | Ender Diagnostics is based in Bern with a US subsidiary with offices in New Jersey and Miami. The st... | startuptic... |
| 25.11.2020 | Development milestones for startups with Corona solutions | | startuptic... |
| 28.10.2020 | Novartis joins Molecular Partners as investor and collaborat... | | startuptic... |
| 28.10.2020 | Novartis joins Molecular Partners as investor and collaborat... | The DARPin therapeutics program developed by Molecular Partners is a new class of custom-built prote... | startuptic... |
| 11.08.2020 | Swiss Government to buy anti-COVID-19 drugs from Molecular P... | Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-bui... | startuptic... |
| 11.08.2020 | Swiss Government to buy anti-COVID-19 drugs from Molecular P... | | startuptic... |
| 07.07.2020 | Molecular Partners raises CHF80 million via private placemen... | | startuptic... |
| 07.07.2020 | Molecular Partners raises CHF80 million via private placemen... | Ten days after the announcement of a major setback regarding the marketing approval of its most adva... | startuptic... |
| 26.06.2020 | Major setback for Molecular Partners | Molecular Partners and Allergan, an AbbVie Company today announced that the U.S. Food and Drug Admin... | startuptic... |
| 26.06.2020 | Major setback for Molecular Partners | | startuptic... |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | | startuptic... |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | BIO International Convention has transformed into BIO Digital to bring together players in the biote... | startuptic... |
| 19.07.2019 | Medicxi closes a €400M Fund to back biopharma entrepreneurs... | | startuptic... |
| 19.07.2018 | Positive phase 3 results for Molecular Partner’s most advanc... | | startuptic... |
| 21.06.2018 | AdoRx raises $10M for adenosine program in cancer; Mole... | → A day after iTeos raised $75 million to accelerate its research plans on an adenosine prog... | endpts.com... |
| 03.01.2018 | Two biotech startups receive milestone payments | | startuptic... |
| 19.05.2017 | Peer Review: Former FDA Commish Califf will split his tim... | → After a little over a year and a half at Alphabet’s Verily, neuroscientist Dr. Thomas In... | endpts.com... |
| 10.12.2015 | Molecular Partners among the best newcomers at European stoc... | | startuptic... |
| 09.11.2015 | Molecular Partner’s DARPins may help reshape anticancer trea... | | startuptic... |
| 07.10.2015 | Molecular Partners honoured for its pioneering technology | | startuptic... |
| 22.07.2015 | Allergan reinforces commitment to Molecular Partners | | startuptic... |
| 07.07.2015 | Molecular Partners receives USD 15 million milestone payment | | startuptic... |
| 09.12.2014 | Milestone payment from Janssen for Molecular Partners | | startuptic... |
| 08.10.2014 | Molecular Partners: First trading day expected for 22 Octobe... | | startuptic... |
| 23.09.2014 | Molecular Partners launches IPO on SIX Swiss Exchange | | startuptic... |
| 22.09.2014 | Molecular Partners one of the most promising biotech compani... | | startuptic... |
| 03.07.2014 | Molecular Partners: Phase III development of a DARPin on the... | | startuptic... |
| 04.12.2013 | Molecular Partners enters into another billion dollar allian... | | startuptic... |
| 17.01.2013 | Molecular Partners publishes encouraging results of a clinic... | | startuptic... |
| 12.11.2012 | Molecular Partners and Boehringer have entered into a strate... | Under the terms of the agreement, Boehringer Ingelheim will be responsible for the generation of the... | startuptic... |
| 21.08.2012 | Molecular Partners signs Billion Dollar Contract with Allerg... | | startuptic... |
| 27.06.2012 | Climeworks gewinnt den Preis der Preisträger bei den de Vigi... | | startuptic... |
| 19.06.2012 | Index Ventures raises EUR350m for new early stage technology... | | startuptic... |
| 05.04.2012 | Compound from Molecular Partners is safe and well tolerated | Normal 0 21 false false false DE-CH X-NONE X-NONE | startuptic... |
| 08.12.2011 | Molecular Partners enters into a Strategic Collaboration wit... | | startuptic... |
| 15.12.2009 | Molecular Partners Secures CHF 46 Million in Series B Financ... | - | jnjinnovat... |
| 15.12.2009 | Switzerland, Molecular Partners Secures CHF46M in Series B F... | Molecular Partners AG, a Zurich, Switzerland-based developer of protein therapeutics, has announced ... | finsmes.co... |
| 16.01.2008 | Life sciences briefing: Wednesday, Jan. 16, 2008 | TODAY’S HEADLINES:
Drug-screening tool maker IonGate Bio raises €4.6M (release)
Protein-drug maker M... | venturebea... |
| 15.08.2007 | Life sciences briefing: Wednesday, Aug. 15, 2007 | (UPDATED at 5:55pm PT: See below.)
Featured companies: Sierra Surgical Technologies, HerbalScience N... | venturebea... |
